Quantitative analysis of the brain

Who are you?
Psychiatrist
Patient
Radiologist
ABOUT US

Neurodiversity
at a glance

At QuantaBrain, we develop software to diagnose and suggest personalized treatments for neurodevelopmental and neuropsychiatric disorders using a quick 1-minute magnetic resonance (MR) exam.

Our method identifies changes in brain activity and gives clear, objective and
quantitative results.

We are revolutionizing the
conventional one-size-fits-all
diagnostic and treatment approaches.

Many neurodevelopmental and
neuropsychiatric disorders that currently fall
under the same disease category have very
different biological bases. Our method
extracts individual brain activity signatures that prove invaluable in crafting individualized
treatment plans.
Patient safety is a top priority.
Our test is safe – it does not require sedation, and it does not use harmful radiation.

VALUE

The brain is complex, but psychiatry
should not be

FAST

1-minute MR exam

SAFE

Safe & sedation-free

OBJECTIVE

Based on biological data

INFORMATIVE

Report on brain atypical functioning

VALUE

The brain is complex, but psychiatry should not be

FAST

1-minute MR exam

SAFE

Safe & sedation-free

OBJECTIVE

Based on biological data

INFORMATIVE

Report on brain atypical functioning

TECNOLOGIA

AI-powered MRI to identify
atypical brain activity

QuantaBrain has pioneered proprietary
AI-driven software for diagnosing psychiatric disorders through a quick 1-minute resting state functional magnetic resonance imaging (rs-fMRI) examination.

rs-fMRI is an entirely safe and non-invasive procedure where the patient simply rests (with the option to keep their eyes open or closed) for 1 minute inside the magnetic resonance scanner. Unlike structural imaging, functional MRI measures the flow of oxygenated blood in the brain. As neural activity consumes oxygen, this examination provides an indirect measurement of brain activity.
Our proprietary AI software leverages urban traffic analysis techniques to analyze how oxygen is delivered and consumed across the brain. It is compatible with any scanner and MR acquisition sequence.

TEAM

We are a multidisciplinary team
with expertise in: AI, medical imaging, genetics
and neurophysiology

Our common belief?
The next major health challenge lies in psychiatry

ELISA FERRARI

CEO and co-founder

PIETRO CARRA

CTO

HANNAH TEICHMANN

Co-founder and advisor
CEO of MedRA

DAVIDE BACCIU

Co-founder
Professor of AI at University of Pisa

ALESSANDRO CELLERINO

Co-founder
Professor of Neurogenetics at Normale

ALESSANDRA RETICO

Co-founder
Researcher at INFN

FRANCESCO PEZCOLLER

Legal advisor
Expert of venture capital and private equity

SALVATORE VISCOMI

Strategic advisor
CEO and co-founder of Carna Health

CONTACTS

Get in touch
with us!

Contact Form